Greg Kunst

Company: Aurion Biotech

Job title: President, CEO

Seminars:

10am – 12pm Navigating Through a New Complex Regulatory Landscape to Drive Future Product Development 12:15 am

The allogeneic industry is truly setting a trailblazing fire to the cell therapy field – however the price of such an evolving and innovating space is an unclear regulator landscape. Join this session to take a deep dive into the perspectives of regulatory agencies, and discover acceptance criteria for gene edits, toxicity, potency assay requirements…Read more

day: Pre-Conference: Supply/Storage

1pm – 3pm Turning a Universal Dream into a Commercial Reality 12:45 am

The holy grail of cell therapy is to develop a cost-effective universal cell therapy that can be manufactured quickly at a large scale to bring life-saving treatments to thousands of patients in need. With innovations in gene engineering, manufacturing and more steaming ahead, the question of how to successfully bring allogeneic product to commercialisation is…Read more

day: Pre-Conference: Supply/Storage